OTUD4 deubiquitination stabilizes EGFR and activates the PI3K/AKT pathway to promote the invasiveness of triple-negative breast cancer
Yu Ren, Fulin Zhou, Zhihua Tan, Senguo Yang, Shaolin Zhang, Yonglin Zhang, Yumei Fu, Mai Zhang, Shu Liu
TL;DR
This study shows that OTUD4 promotes the spread of triple-negative breast cancer by stabilizing EGFR and activating the PI3K/AKT pathway.
Contribution
The novel finding is that OTUD4 stabilizes EGFR through direct interaction and ubiquitin cleavage, promoting TNBC invasiveness.
Findings
OTUD4 is overexpressed in triple-negative breast cancer and correlates with poor prognosis.
OTUD4 stabilizes EGFR by cleaving K48-linked ubiquitin chains and through direct interaction with EGFR.
OTUD4 is recruited by NRP1 to further stabilize EGFR, promoting cancer progression.
Abstract
The deubiquitinating enzyme OTUD4 functions as an oncogene in various cancers, but its role in triple-negative breast cancer (TNBC) remains unclear. Through bioinformatics analysis and experimental validation, we demonstrate that OTUD4 is overexpressed in TNBC and correlates with poor prognosis. OTUD4 downregulation reduces TNBC invasiveness, highlighting its oncogenic role. Mechanistically, OTUD4 promotes TNBC progression by stabilizing EGFR expression and activating the PI3K/AKT pathway. This stabilization occurs through two mechanisms: direct interaction between OTUD4 (568–1114aa) and EGFR (958-1210aa) and OTUD4-mediated cleavage of K48-linked polyubiquitin chains. Additionally, OTUD4 is recruited by NRP1 to deubiquitinate and further stabilize EGFR. These findings enhance our understanding of EGFR signaling in TNBC and may inform novel therapeutic strategies.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsUbiquitin and proteasome pathways · Lung Cancer Treatments and Mutations · Microtubule and mitosis dynamics